| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 1.18e-04 | 10 | 33 | 2 | GO:0034596 | |
| Domain | KRAB | 2.77e-03 | 358 | 31 | 4 | PS50805 | |
| Domain | KRAB | 2.77e-03 | 358 | 31 | 4 | PF01352 | |
| Domain | KRAB | 3.09e-03 | 369 | 31 | 4 | SM00349 | |
| Domain | KRAB | 3.12e-03 | 370 | 31 | 4 | IPR001909 | |
| Domain | Sushi | 3.36e-03 | 52 | 31 | 2 | PF00084 | |
| Domain | CCP | 3.62e-03 | 54 | 31 | 2 | SM00032 | |
| Domain | SUSHI | 3.88e-03 | 56 | 31 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 4.02e-03 | 57 | 31 | 2 | IPR000436 | |
| Domain | Znf_C2H2-like | 9.39e-03 | 796 | 31 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 9.83e-03 | 805 | 31 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 9.98e-03 | 808 | 31 | 5 | SM00355 | |
| Domain | Galactose-bd-like | 1.06e-02 | 94 | 31 | 2 | IPR008979 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21143350 | ||
| Pubmed | What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome? | 9.28e-07 | 2 | 34 | 2 | 23369858 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22483866 | ||
| Pubmed | An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. | 9.28e-07 | 2 | 34 | 2 | 18369450 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23028371 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23467542 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 24101214 | ||
| Pubmed | Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway. | 9.26e-06 | 5 | 34 | 2 | 25869668 | |
| Pubmed | 7.19e-05 | 13 | 34 | 2 | 26989192 | ||
| Pubmed | 7.19e-05 | 13 | 34 | 2 | 25847297 | ||
| Pubmed | 1.10e-04 | 16 | 34 | 2 | 37727456 | ||
| Pubmed | 1.57e-04 | 19 | 34 | 2 | 24165912 | ||
| Pubmed | Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. | 4.24e-04 | 31 | 34 | 2 | 15583024 | |
| Pubmed | 6.38e-04 | 38 | 34 | 2 | 20214802 | ||
| Pubmed | 6.38e-04 | 38 | 34 | 2 | 22952603 | ||
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 6.72e-04 | 39 | 34 | 2 | 19010793 | |
| Pubmed | 9.75e-04 | 47 | 34 | 2 | 26687681 | ||
| Cytoband | 19p13.2 | 2.49e-05 | 229 | 34 | 4 | 19p13.2 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.50e-03 | 57 | 28 | 2 | 1179 | |
| Drug | azotochelin | 2.16e-06 | 2 | 34 | 2 | CID000193592 | |
| Disease | blood manganese measurement | 3.33e-06 | 27 | 32 | 3 | EFO_0007581 | |
| Disease | clostridium difficile infection | 1.76e-05 | 144 | 32 | 4 | EFO_0009130 | |
| Disease | aspartate aminotransferase measurement | 4.26e-05 | 904 | 32 | 7 | EFO_0004736 | |
| Disease | glycodeoxycholate measurement | 1.03e-04 | 14 | 32 | 2 | EFO_0010493 | |
| Disease | granulysin measurement | 1.19e-04 | 15 | 32 | 2 | EFO_0008144 | |
| Disease | cortical thickness change measurement | 1.72e-04 | 18 | 32 | 2 | EFO_0021501 | |
| Disease | malaria | 1.85e-04 | 102 | 32 | 3 | EFO_0001068 | |
| Disease | mood instability measurement | 3.61e-04 | 128 | 32 | 3 | EFO_0008475 | |
| Disease | neuritic plaque measurement | 5.32e-04 | 349 | 32 | 4 | EFO_0006798 | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 5.54e-04 | 32 | 32 | 2 | EFO_0007663, EFO_0007826 | |
| Disease | cognitive function measurement, self reported educational attainment | 5.68e-04 | 355 | 32 | 4 | EFO_0004784, EFO_0008354 | |
| Disease | attempted suicide | 9.41e-04 | 178 | 32 | 3 | EFO_0004321 | |
| Disease | diffuse plaque measurement | 1.25e-03 | 758 | 32 | 5 | EFO_0010699 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.34e-03 | 447 | 32 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | response to cisplatin, platinum measurement | 1.52e-03 | 53 | 32 | 2 | EFO_0010154, GO_0072718 | |
| Disease | behavior | 1.63e-03 | 55 | 32 | 2 | GO_0007610 | |
| Disease | creatine kinase measurement | 1.88e-03 | 59 | 32 | 2 | EFO_0004534 | |
| Disease | parental longevity | 1.92e-03 | 494 | 32 | 4 | EFO_0007796 | |
| Disease | non-lobar intracerebral hemorrhage | 2.14e-03 | 63 | 32 | 2 | EFO_0010178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKPGYVSRGGMRKFI | 51 | P02749 | |
| VGSKVHYFCKPGYRM | 2451 | Q96PZ7 | |
| FPKRGQTCVVHYTGM | 16 | P62942 | |
| LKSVFGGAICRMYRF | 221 | Q96PE3 | |
| GVFGRCQKVPAMDFY | 56 | Q92932 | |
| YVRGHGKLRFAPRMC | 76 | Q8TAE7 | |
| MVPYFGRHGCKQFIR | 741 | P0DP91 | |
| MAICQHFYKRGNIYP | 156 | Q8TDD5 | |
| HMVGRRCEQVQPGYF | 546 | P55268 | |
| RCIMVTPDGNFHRGY | 131 | Q8TD46 | |
| FMVFGFIIGRRHCGY | 571 | Q15375 | |
| CRVLRPGGAFYFMEH | 161 | Q9H8H3 | |
| AILMHFPFCGPRKVY | 161 | Q8NHA4 | |
| GQRYIMKEGRPYCCH | 231 | Q7Z3G6 | |
| FYLVGKRCMEIFGPR | 206 | Q9NTQ9 | |
| RNFYHVPFGFGMRQC | 436 | P15538 | |
| HRKPMFNIHRGFYCL | 11 | Q6P179 | |
| RRCRAGVVFMAGHVY | 336 | Q9UH77 | |
| RVHMGRKPGYFSFLD | 526 | Q16478 | |
| GFAKPMDIYCHRFVQ | 951 | Q9Y2H2 | |
| EFMVPYFGRHGCKQF | 271 | Q8N328 | |
| GPQHGHLQYFKRCMV | 871 | P0C091 | |
| HLQYFKRCMVPGESF | 876 | P0C091 | |
| LGHKAGCRHRFMEPY | 91 | Q9Y399 | |
| LGIYMHAPKRGQFCI | 356 | Q12769 | |
| RHMAVQRGDGPYKCK | 186 | Q96GE5 | |
| LCYVKMPSFQHGPGR | 51 | Q9BZ98 | |
| IPTCMGFGVHQDKYR | 241 | Q8IV63 | |
| MRHLPYFCRGQVVRG | 1 | Q969G6 | |
| RHMVVQGGNRPYKCK | 186 | Q8TA94 | |
| RHMAVQRGDGPYKCK | 186 | Q9Y2A4 | |
| GHRCLIYPFLMRGGK | 96 | P18405 | |
| QPKQRGMRFRYKCEG | 26 | Q04206 | |
| KVRLYYMLHPRDGGC | 41 | Q9H898 | |
| GKVFGYPSCLNNHMR | 426 | Q9BUY5 | |
| MFQHREGCVPRYHKA | 996 | O75385 |